Literature DB >> 30098347

Comparing Outcomes of Phacoemulsification With Femtosecond Laser-Assisted Cataract Surgery in Patients With Fuchs Endothelial Dystrophy.

Wei Wei Dayna Yong1, Hui-Chen Charmaine Chai2, Liang Shen3, Ray Manotosh4, Wee Tien Anna Tan5.   

Abstract

PURPOSE: To compare the outcome in patients with Fuchs endothelial dystrophy (FED) who underwent standard phacoemulsification vs femtosecond laser-assisted cataract surgery (FLACS) in the treatment of visually significant cataracts.
DESIGN: Retrospective, comparative, interventional case series.
METHODS: Patient or Study Population: Between April 2013 and December 2016, 140 FED eyes with cataracts of all densities were included. Seventy-two eyes underwent phacoemulsification and 68 eyes underwent FLACS. Intervention or Observation Procedures: Automated noncontact specular microscopy was performed at baseline and postoperatively over a mean of 17.91 ± 10.47 months. Parameters collected include visual acuity, slit-lamp examination findings, and intraoperative findings. MAIN OUTCOME MEASURES: Pachymetry, endothelial cell density (ECD), and coefficient of variance (COV) were compared.
RESULTS: Phacoemulsification had significantly greater postoperative median loss of ECD of 229.0 cells/mm2 (14.2%) compared to FLACS ECD of 133.0 cells/mm2 (6.5%) (U = 1343.0, Z = -2.241, P = .025). Mean loss of ECD was 346.524 ± 420.472 cells/mm2 and 119.964 ± 434.882 cells/mm2 for phacoemulsification and FLACS, respectively (P = .005). Mean percentage loss of ECD was 15.3% ± 17.5% for phacoemulsification and 4.4% ± 25.0% for FLACS (P = .006). Eyes that underwent phacoemulsification had 10.7% ± 15.4% mean ECD loss in the mild cataract group, and in the moderate/hard cataract group 19.5% ± 18.0%, P = .045. Eyes that underwent FLACS had 0.9% ± 22.5% mean ECD loss in the mild cataract group, and 8.2% ± 26.3% in the moderate/hard cataract group, P = .291. Comparison between procedures of mean ECD loss for moderate/hard cataracts was significant (P = .043).
CONCLUSIONS: FLACS is shown to be superior to phacoemulsification in reducing postoperative endothelial cell loss in FED patients, which translates to a lower risk of corneal decompensation, especially in patients with moderate/hard cataract densities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30098347     DOI: 10.1016/j.ajo.2018.08.006

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Refractive Outcomes in Fuchs' Endothelial Corneal Dystrophy: Conventional and Femtosecond Laser-Assisted Cataract Surgery.

Authors:  Ellen H Koo; Vikram Paranjpe; William J Feuer; Patrice J Persad; Kendall E Donaldson
Journal:  Clin Ophthalmol       Date:  2021-08-12

2.  Endothelial Cell Loss, Cumulative Dissipated Energy, and Surgically Induced Astigmatism in Sutureless Scleral Tunnel Phaco-Assisted Cataract Extraction in Advanced Cataracts.

Authors:  Marwa M Salama; Sherif A GamalElDin; Malak I ElShazly
Journal:  J Ophthalmol       Date:  2022-05-17       Impact factor: 1.974

3.  Clinical outcomes and complications between FLACS and conventional phacoemulsification cataract surgery: a PRISMA-compliant Meta-analysis of 25 randomized controlled trials.

Authors:  Li Chen; Chen Hu; Xiao Lin; Hao-Yu Li; Yi Du; Yi-Hua Yao; Jun Chen
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

4.  Comparison of Femtosecond Laser-Assisted Cataract Surgery and Conventional Phacoemulsification in Shallow Anterior Chambers and Glaucoma.

Authors:  Zhou Zhou; Li Li; Siming Zeng; Wenjing He; Min Li
Journal:  J Ophthalmol       Date:  2020-11-16       Impact factor: 1.909

Review 5.  Phacoemulsification in the Setting of Corneal Endotheliopathies: A Review.

Authors:  Victoria S Chang; Allister Gibbons; Carla Osigian
Journal:  Int Ophthalmol Clin       Date:  2020

6.  Clinical and Surgical Outcomes of Femtosecond Laser-Assisted Cataract Surgery (FLACS) on Hard Cataracts in the Egyptian Population.

Authors:  Mohamed Gamal Ebidalla Elghobaier; Mohamed Farag Khalil Ibrahiem; Ahmed Shawkat Abdelhalim; Ahmed Mostafa Eid; Khalid Al Said Murad
Journal:  Clin Ophthalmol       Date:  2020-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.